Medicare’s Registry Plans For Leqembi Prompt New Calls For Transparency, Rigor

Now that it’s clear the Centers for Medicare and Medicaid Services is moving ahead with the patient registry requirement for the Alzheimer’s drug, experts weigh in on how best to collect useful information.